{"id":1663,"date":"2016-06-27T15:05:47","date_gmt":"2016-06-27T14:05:47","guid":{"rendered":"http:\/\/actubusinessangels.com\/?p=1663"},"modified":"2016-06-27T15:05:47","modified_gmt":"2016-06-27T14:05:47","slug":"xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant","status":"publish","type":"post","link":"https:\/\/www.franceangels.org\/en\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/","title":{"rendered":"Xenothera l\u00e8ve 2M\u20ac pour le d\u00e9veloppement d’un immunosuppresseur innovant"},"content":{"rendered":"

La startup Xenothera<\/a> vient de boucler une seconde lev\u00e9e de fonds de 2 millions d’euros aupr\u00e8s de ses investisseurs historiques et de nouveaux investisseurs. Le fonds Pays de la Loire D\u00e9veloppement<\/a>, les Business Angels du Grand-Ouest<\/a> (ABAB), et des investisseurs priv\u00e9s ont renouvel\u00e9 leur confiance dans le projet de la startup. De nouveaux investisseurs ont \u00e9galement fait leur entr\u00e9e dans XENOTHERA : le fonds Starquest<\/a> 2016, le fonds r\u00e9gional de co-investissement Id\u00e9e<\/a>, les Business Angels des Arts et M\u00e9tiers<\/a> (AMBA).<\/p>\n

\"Xenothera-LogoBLEU-2lignesRVB\"<\/p>\n

La soci\u00e9t\u00e9 d\u00e9veloppe une nouvelle g\u00e9n\u00e9ration de m\u00e9dicaments antirejet : il s’agit d’un immunosuppresseur bas\u00e9 sur un brevet de l’Inserm, du CHU et de l’universit\u00e9 de Nantes. N\u00e9 en 2014, Xenothera associe une \u00e9quipe m\u00e9dicale sp\u00e9cialiste des greffes et un v\u00e9t\u00e9rinaire mondialement reconnu dans le domaine du clonage, Cesare Galli, fondateur de l’entreprise italienne Avantea<\/a>. Apr\u00e8s leur premi\u00e8re lev\u00e9e de fonds, XENOTHERA a obtenu des avanc\u00e9es majeures sur l\u2019int\u00e9r\u00eat de son produit pour les patients greff\u00e9s (Journal of Clinical Investigation, 2015) et sur son d\u00e9veloppement pharmaceutique. La startup est incub\u00e9e \u00e0 Atlanpole<\/a> et b\u00e9n\u00e9ficie du soutien des fonds publics de BPI<\/a> et de la r\u00e9gion Pays de la Loire. Elle a fait partie de la s\u00e9lection r\u00e9gionale du concours Cr\u00e9ation D\u00e9veloppement du Minist\u00e8re de la Recherche en 2014.<\/p>\n

Cette nouvelle lev\u00e9e de fonds permettra \u00e0 XENOTHERA de mener \u00e0 bien les principales \u00e9tapes avant l\u2019essai clinique qui doit permettre aux premiers patients de b\u00e9n\u00e9ficier de son innovation. L\u2019\u00e9quipe XENOTHERA est dirig\u00e9e par le Dr Odile DUVAUX, entour\u00e9e de grands noms de la recherche m\u00e9dicale, en particulier les professeurs Jean-Paul Soulillou (Universit\u00e9 de Nantes) et Jean-Marie Bach (Ecole V\u00e9t\u00e9rinaire ONIRIS).<\/p>\n

Lire le communiqu\u00e9 de presse<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

La startup Xenothera vient de boucler une seconde lev\u00e9e de fonds de 2 millions d’euros aupr\u00e8s de ses investisseurs historiques et de nouveaux investisseurs. Le fonds Pays de la Loire D\u00e9veloppement, les Business Angels du Grand-Ouest (ABAB), et des investisseurs priv\u00e9s ont renouvel\u00e9 leur confiance dans le projet de la startup.<\/p>\n","protected":false},"author":114,"featured_media":1697,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false},"categories":[85,86],"tags":[63,78,72,75,76,93],"yoast_head":"\nXenothera l\u00e8ve 2M\u20ac pour le d\u00e9veloppement d'un immunosuppresseur innovant - France Angels<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Xenothera l\u00e8ve 2M\u20ac pour le d\u00e9veloppement d'un immunosuppresseur innovant - France Angels\" \/>\n<meta property=\"og:description\" content=\"La startup Xenothera vient de boucler une seconde lev\u00e9e de fonds de 2 millions d’euros aupr\u00e8s de ses investisseurs historiques et de nouveaux investisseurs. Le fonds Pays de la Loire D\u00e9veloppement, les Business Angels du Grand-Ouest (ABAB), et des investisseurs priv\u00e9s ont renouvel\u00e9 leur confiance dans le projet de la startup.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/\" \/>\n<meta property=\"og:site_name\" content=\"France Angels\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/france.angels\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-06-27T14:05:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2016\/06\/odile-duvaux-photo-dec-2015-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1386\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"France Angels\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@franceangels\" \/>\n<meta name=\"twitter:site\" content=\"@franceangels\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"France Angels\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/\"},\"author\":{\"name\":\"France Angels\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59\"},\"headline\":\"Xenothera l\u00e8ve 2M\u20ac pour le d\u00e9veloppement d’un immunosuppresseur innovant\",\"datePublished\":\"2016-06-27T14:05:47+00:00\",\"dateModified\":\"2016-06-27T14:05:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/\"},\"wordCount\":329,\"commentCount\":1,\"publisher\":{\"@id\":\"https:\/\/www.franceangels.org\/#organization\"},\"keywords\":[\"Business Angels\",\"France Angels\",\"Investissements\",\"Lev\u00e9e de fonds\",\"R\u00e9seaux de Business Angels\",\"Start-up\"],\"articleSection\":[\"Closing\",\"Les entreprises financ\u00e9es\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/\",\"url\":\"https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/\",\"name\":\"Xenothera l\u00e8ve 2M\u20ac pour le d\u00e9veloppement d'un immunosuppresseur innovant - France Angels\",\"isPartOf\":{\"@id\":\"https:\/\/www.franceangels.org\/#website\"},\"datePublished\":\"2016-06-27T14:05:47+00:00\",\"dateModified\":\"2016-06-27T14:05:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.franceangels.org\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Xenothera l\u00e8ve 2M\u20ac pour le d\u00e9veloppement d’un immunosuppresseur innovant\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.franceangels.org\/#website\",\"url\":\"https:\/\/www.franceangels.org\/\",\"name\":\"France Angels\",\"description\":\"F\u00e9d\u00e9ration Nationale des Business Angels\",\"publisher\":{\"@id\":\"https:\/\/www.franceangels.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.franceangels.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.franceangels.org\/#organization\",\"name\":\"France Angels\",\"url\":\"https:\/\/www.franceangels.org\/\",\"sameAs\":[\"https:\/\/linkedin.com\/company\/france-angels\",\"https:\/\/www.youtube.com\/channel\/UC5_t1C5xO9AloWjY4o5ob_Q\",\"https:\/\/facebook.com\/france.angels\/\",\"https:\/\/twitter.com\/franceangels\"],\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png\",\"contentUrl\":\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png\",\"width\":4033,\"height\":1173,\"caption\":\"France Angels\"},\"image\":{\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59\",\"name\":\"France Angels\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g\",\"caption\":\"France Angels\"},\"url\":\"https:\/\/www.franceangels.org\/en\/article\/author\/france-angels\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Xenothera l\u00e8ve 2M\u20ac pour le d\u00e9veloppement d'un immunosuppresseur innovant - France Angels","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/","og_locale":"en_US","og_type":"article","og_title":"Xenothera l\u00e8ve 2M\u20ac pour le d\u00e9veloppement d'un immunosuppresseur innovant - France Angels","og_description":"La startup Xenothera vient de boucler une seconde lev\u00e9e de fonds de 2 millions d’euros aupr\u00e8s de ses investisseurs historiques et de nouveaux investisseurs. Le fonds Pays de la Loire D\u00e9veloppement, les Business Angels du Grand-Ouest (ABAB), et des investisseurs priv\u00e9s ont renouvel\u00e9 leur confiance dans le projet de la startup.","og_url":"https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/","og_site_name":"France Angels","article_publisher":"https:\/\/facebook.com\/france.angels\/","article_published_time":"2016-06-27T14:05:47+00:00","og_image":[{"width":2560,"height":1386,"url":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2016\/06\/odile-duvaux-photo-dec-2015-scaled.jpg","type":"image\/jpeg"}],"author":"France Angels","twitter_card":"summary_large_image","twitter_creator":"@franceangels","twitter_site":"@franceangels","twitter_misc":{"Written by":"France Angels","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/#article","isPartOf":{"@id":"https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/"},"author":{"name":"France Angels","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59"},"headline":"Xenothera l\u00e8ve 2M\u20ac pour le d\u00e9veloppement d’un immunosuppresseur innovant","datePublished":"2016-06-27T14:05:47+00:00","dateModified":"2016-06-27T14:05:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/"},"wordCount":329,"commentCount":1,"publisher":{"@id":"https:\/\/www.franceangels.org\/#organization"},"keywords":["Business Angels","France Angels","Investissements","Lev\u00e9e de fonds","R\u00e9seaux de Business Angels","Start-up"],"articleSection":["Closing","Les entreprises financ\u00e9es"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/","url":"https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/","name":"Xenothera l\u00e8ve 2M\u20ac pour le d\u00e9veloppement d'un immunosuppresseur innovant - France Angels","isPartOf":{"@id":"https:\/\/www.franceangels.org\/#website"},"datePublished":"2016-06-27T14:05:47+00:00","dateModified":"2016-06-27T14:05:47+00:00","breadcrumb":{"@id":"https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.franceangels.org\/article\/xenothera-leve-2me-pour-le-developpement-dun-immunosuppresseur-innovant\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.franceangels.org\/en\/"},{"@type":"ListItem","position":2,"name":"Xenothera l\u00e8ve 2M\u20ac pour le d\u00e9veloppement d’un immunosuppresseur innovant"}]},{"@type":"WebSite","@id":"https:\/\/www.franceangels.org\/#website","url":"https:\/\/www.franceangels.org\/","name":"France Angels","description":"F\u00e9d\u00e9ration Nationale des Business Angels","publisher":{"@id":"https:\/\/www.franceangels.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.franceangels.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.franceangels.org\/#organization","name":"France Angels","url":"https:\/\/www.franceangels.org\/","sameAs":["https:\/\/linkedin.com\/company\/france-angels","https:\/\/www.youtube.com\/channel\/UC5_t1C5xO9AloWjY4o5ob_Q","https:\/\/facebook.com\/france.angels\/","https:\/\/twitter.com\/franceangels"],"logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png","contentUrl":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png","width":4033,"height":1173,"caption":"France Angels"},"image":{"@id":"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59","name":"France Angels","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g","caption":"France Angels"},"url":"https:\/\/www.franceangels.org\/en\/article\/author\/france-angels\/"}]}},"_links":{"self":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts\/1663"}],"collection":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/users\/114"}],"replies":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/comments?post=1663"}],"version-history":[{"count":0,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts\/1663\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/media\/1697"}],"wp:attachment":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/media?parent=1663"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/categories?post=1663"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/tags?post=1663"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}